Cardiology Activities
Novel Reversal Agents to Safely and Effectively Treat Direct Oral Anticoagulant Bleeding: Education for the Health-System Pharmacist
0290-0000-21-132-L01-P
Analyze clinical data and real-world evidence comparing the safety benefits of specific reversal agents over prothrombin complex concentrates for reversing life-threatening DOAC-related bleeding
6-01-2021
1.00
Hyperlipidemia: Effective Disease Management to Decrease Economic and Quality of Life Burden
0290-0000-21-080-H01-P
This activity will help managed care professionals become more aware of the prevalence of hyperlipidemia and opportunities to optimize care of patients with elevated cholesterol using a more aggressive treatment approach.
3.00
Advancements in Cardiovascular Disease Beyond Statins: Clinical Data and Evidence for Omega-3 Fatty Acids
0290-0000-21-071-H01-P
This activity will provide practical information on the evidence, clinical utility, and use of omega-3 prescription products as adjuncts to statin therapy in patients with residual risk for ASCVD-related events.
2.00
Continuing the Conversation: Improving CAD/PAD Care Through Pharmacist Intervention
0290-0000-21-069-H01-P
This activity will focus on the pharmacist’s role in working with the health care team to improve quality of care and outcomes in patients with CAD and PAD. Clinical vignettes highlighting the patient encounter will be presented and assessed by the faculty.
0.50